Jade Biosciences (JBIO) Preferred Shares (2025 - 2026)
Jade Biosciences (JBIO) reported Preferred Shares of $2000.0 for Q1 2026, little changed quarter-over-quarter from $2000.0 in Q4 2025.
Jade Biosciences (JBIO) Preferred Shares (2025 - 2026) Analysis & Trends
Jade Biosciences has reported Preferred Shares for 2 years, with the latest figure at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Preferred Shares changed N/A year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $2000.0 (changed N/A YoY), and the FY2025 full-year result was $2000.0, changed N/A from the prior year.
- Preferred Shares for Q1 2026 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
- The five-year high for Preferred Shares was $2000.0 in Q2 2025, with the low at $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |